183 related articles for article (PubMed ID: 34001624)
1. Circulating immunity protects the female reproductive tract from
Labuda JC; Pham OH; Depew CE; Fong KD; Lee BS; Rixon JA; McSorley SJ
Proc Natl Acad Sci U S A; 2021 May; 118(21):. PubMed ID: 34001624
[TBL] [Abstract][Full Text] [Related]
2.
Shillova N; Howe SE; Hyseni B; Ridgell D; Fisher DJ; Konjufca V
Infect Immun; 2020 Dec; 89(1):. PubMed ID: 33139380
[No Abstract] [Full Text] [Related]
3. The
Verma R; Sahu R; Dixit S; Duncan SA; Giambartolomei GH; Singh SR; Dennis VA
Front Immunol; 2018; 9():2369. PubMed ID: 30374357
[TBL] [Abstract][Full Text] [Related]
4. Antigen-specific CD4+ T cells produce sufficient IFN-gamma to mediate robust protective immunity against genital Chlamydia muridarum infection.
Li W; Murthy AK; Guentzel MN; Seshu J; Forsthuber TG; Zhong G; Arulanandam BP
J Immunol; 2008 Mar; 180(5):3375-82. PubMed ID: 18292563
[TBL] [Abstract][Full Text] [Related]
5. Intranasal vaccination with a secreted chlamydial protein enhances resolution of genital Chlamydia muridarum infection, protects against oviduct pathology, and is highly dependent upon endogenous gamma interferon production.
Murthy AK; Chambers JP; Meier PA; Zhong G; Arulanandam BP
Infect Immun; 2007 Feb; 75(2):666-76. PubMed ID: 17118987
[TBL] [Abstract][Full Text] [Related]
6. Th1/Th17 T cell Tissue-Resident Immunity Increases Protection, But Is Not Required in a Vaccine Strategy Against Genital Infection With
Nguyen NDNT; Guleed S; Olsen AW; Follmann F; Christensen JP; Dietrich J
Front Immunol; 2021; 12():790463. PubMed ID: 34925371
[TBL] [Abstract][Full Text] [Related]
7. CCR7 Deficiency Allows Accelerated Clearance of
Li LX; Labuda JC; Imai DM; Griffey SM; McSorley SJ
J Immunol; 2017 Oct; 199(7):2547-2554. PubMed ID: 28801359
[TBL] [Abstract][Full Text] [Related]
8. Protection against Chlamydia promoted by a subunit vaccine (CTH1) compared with a primary intranasal infection in a mouse genital challenge model.
Olsen AW; Theisen M; Christensen D; Follmann F; Andersen P
PLoS One; 2010 May; 5(5):e10768. PubMed ID: 20505822
[TBL] [Abstract][Full Text] [Related]
9. Innate IFN-γ Is Essential for Systemic Chlamydia muridarum Control in Mice, While CD4 T Cell-Dependent IFN-γ Production Is Highly Redundant in the Female Reproductive Tract.
Mercado MAB; Du W; Malaviarachchi PA; Gann JI; Li LX
Infect Immun; 2021 Feb; 89(3):. PubMed ID: 33257535
[TBL] [Abstract][Full Text] [Related]
10. Nonpathogenic Colonization with Chlamydia in the Gastrointestinal Tract as Oral Vaccination for Inducing Transmucosal Protection.
Wang L; Zhu C; Zhang T; Tian Q; Zhang N; Morrison S; Morrison R; Xue M; Zhong G
Infect Immun; 2018 Feb; 86(2):. PubMed ID: 29133348
[No Abstract] [Full Text] [Related]
11. Immunological memory in B-cell-deficient mice conveys long-lasting protection against genital tract infection with Chlamydia trachomatis by rapid recruitment of T cells.
Johansson M; Lycke N
Immunology; 2001 Feb; 102(2):199-208. PubMed ID: 11260325
[TBL] [Abstract][Full Text] [Related]
12. CD4+ T cells reduce the tissue burden of Chlamydia muridarum in male BALB/c mice.
Cunningham KA; Carey AJ; Timms P; Beagley KW
Vaccine; 2010 Jul; 28(31):4861-3. PubMed ID: 20653101
[TBL] [Abstract][Full Text] [Related]
13. Estradiol Enhances Antiviral CD4
Bagri P; Ghasemi R; McGrath JJC; Thayaparan D; Yu E; Brooks AG; Stämpfli MR; Kaushic C
J Virol; 2020 Dec; 95(1):. PubMed ID: 33028712
[TBL] [Abstract][Full Text] [Related]
14. Comparison of immune responses and protective efficacy of intranasal prime-boost immunization regimens using adenovirus-based and CpG/HH2 adjuvanted-subunit vaccines against genital Chlamydia muridarum infection.
Brown TH; David J; Acosta-Ramirez E; Moore JM; Lee S; Zhong G; Hancock RE; Xing Z; Halperin SA; Wang J
Vaccine; 2012 Jan; 30(2):350-60. PubMed ID: 22075089
[TBL] [Abstract][Full Text] [Related]
15. B Cell Presentation of Chlamydia Antigen Selects Out Protective CD4γ13 T Cells: Implications for Genital Tract Tissue-Resident Memory Lymphocyte Clusters.
Johnson RM; Yu H; Strank NO; Karunakaran K; Zhu Y; Brunham RC
Infect Immun; 2018 Feb; 86(2):. PubMed ID: 29158429
[TBL] [Abstract][Full Text] [Related]
16. A T cell epitope-based vaccine protects against chlamydial infection in HLA-DR4 transgenic mice.
Li W; Murthy AK; Lanka GK; Chetty SL; Yu JJ; Chambers JP; Zhong G; Forsthuber TG; Guentzel MN; Arulanandam BP
Vaccine; 2013 Nov; 31(48):5722-8. PubMed ID: 24096029
[TBL] [Abstract][Full Text] [Related]
17. Protective immunity against mouse upper genital tract pathology correlates with high IFNγ but low IL-17 T cell and anti-secretion protein antibody responses induced by replicating chlamydial organisms in the airway.
Lu C; Zeng H; Li Z; Lei L; Yeh IT; Wu Y; Zhong G
Vaccine; 2012 Jan; 30(2):475-85. PubMed ID: 22079265
[TBL] [Abstract][Full Text] [Related]
18. Chlamydia muridarum T cell antigens and adjuvants that induce protective immunity in mice.
Yu H; Karunakaran KP; Jiang X; Shen C; Andersen P; Brunham RC
Infect Immun; 2012 Apr; 80(4):1510-8. PubMed ID: 22290151
[TBL] [Abstract][Full Text] [Related]
19. Chlamydia muridarum T-cell antigens formulated with the adjuvant DDA/TDB induce immunity against infection that correlates with a high frequency of gamma interferon (IFN-gamma)/tumor necrosis factor alpha and IFN-gamma/interleukin-17 double-positive CD4+ T cells.
Yu H; Jiang X; Shen C; Karunakaran KP; Jiang J; Rosin NL; Brunham RC
Infect Immun; 2010 May; 78(5):2272-82. PubMed ID: 20231405
[TBL] [Abstract][Full Text] [Related]
20. Transcutaneous immunization with a novel lipid-based adjuvant protects against Chlamydia genital and respiratory infections.
Hickey DK; Aldwell FE; Beagley KW
Vaccine; 2009 Oct; 27(44):6217-25. PubMed ID: 19698810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
